Radiation recall dermatitis induced by erlotinib.
Dauendorffer
Jean-Noël
JN
Dupuy
Alain
A
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000532:radiotherapy; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D011855:Radiodermatitis / Q000139:chemically induced* / Q000473:pathology
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride